Status:
WITHDRAWN
The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome
Lead Sponsor:
Yale University
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
This research study was designed to look at the effect of human albumin transfusion on circulating levels of Vascular Endothelial Derived Growth Factor (VEGF), a protein that is believed to be respons...
Eligibility Criteria
Inclusion
- Infertile patients undergoing in vitro fertilization with or without ICSI
- Estradiol \> 3000 pg/mL at the time of hCG administration
- \>/= 20 follicles seen during ultrasound monitoring
- Patients with polycystic ovarian syndrome
Exclusion
- Patients with only one ovary
- Patients with medical contraindication to human albumin (hypersensitivity, hypervolemia, cardiac insufficiency, hypertension, esophageal varices, pulmonary edema, severe anemia, renal failure)
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00617864
Start Date
September 1 2007
Last Update
February 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Fertility Center
New Haven, Connecticut, United States, 06510